Heart clot showdown: newer blood thinner may beat old standard
NCT ID NCT05825573
First seen Feb 17, 2026 · Last updated May 14, 2026 · Updated 13 times
Summary
This study tests whether a newer type of blood thinner (direct oral anticoagulant, or DOA) works better than the standard older drug (vitamin K antagonist, or VKA) to dissolve blood clots inside the heart. About 340 adults with such clots will be randomly assigned to one of the two treatments. The goal is to see which drug more safely reduces the risk of death, stroke, and bleeding while helping the clot disappear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM CHU La Timone
Marseille, France
-
AP-HP CHU Bichat
Paris, France
-
AP-HP CHU Lariboisière
Paris, France
-
AP-HP Hopital Ambroise Paré
Paris, France
-
Ap-Hp Hegp
Paris, France
-
CH Bastia
Bastia, France
-
CH Chartres
Chartres, France
-
CH Compiègne Noyon
Compiègne, France
-
CH Francois Mitterand
Pau, France
-
CHR Metz-Thionville
Metz, France
-
CHU Angers
Angers, France
-
CHU Arnaud de Villeneuve
Montpellier, France
-
CHU Brest
Brest, France
-
CHU Gabriel Montpied
Clermont-Ferrand, France
-
CHU La réunion NORD
Saint-Denis, Reunion
-
CHU Lille
Lille, France
-
CHU Limoges
Limoges, France
-
CHU Nantes
Nantes, France
-
CHU Nice
Nice, France
-
CHU Pitié-Salpêtrière
Paris, France
-
CHU Poitiers
Potiers, France
-
CHU Rennes
Rennes, France
-
CHU Strasbourg
Strasbourg, France
-
CHU Toulouse
Toulouse, France
-
CHU de Nimes
Nîmes, France
-
Centre Cardiologique du Nord
Saint-Denis, France
-
Centre Hopistalier de Valence
Valence, 26000, France
-
Ch Auxerre
Auxerre, 89000, France
-
Ch Avignon
Avignon, France
-
Ch Bretagne Atlantique
Vannes, 56000, France
-
Clinique du Millenaire
Montpellier, France
-
Groupe Hospitalier Mutualiste
Grenoble, France
-
Hôpital Cardiologique du Haut Lévêque
Bordeaux, France
-
Hôpital Cardiovasculaire Louis Pradel
Lyon, France
-
Hôpital Privé Dijon Bourgogne
Dijon, France
Conditions
Explore the condition pages connected to this study.